Skip to content
Sharism- Lifestyle
Author:
Syncromune
Syncromune to Present Updated Long-Term Overall Survival Data from Phase 1 Trial of SYNC-T Therapy SV-102 in Metastatic Prostate Cancer at ESMO Congress 2026
October 19, 2026
Syncromune® Presents SYNC-T™ Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026
September 9, 2026
Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium
June 16, 2026
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
April 29, 2026